E216-1323 Screening compound: 1-(6-methyl-3,4-dihydro-2H-1,4-benzoxazine-4-carbonyl)-N-[(4-propoxyphenyl)methyl]piperidine-4-carboxamide

E216-1323 Screening compound: 1-(6-methyl-3,4-dihydro-2H-1,4-benzoxazine-4-carbonyl)-N-[(4-propoxyphenyl)methyl]piperidine-4-carboxamide
E216-1323 Screening compound: 1-(6-methyl-3,4-dihydro-2H-1,4-benzoxazine-4-carbonyl)-N-[(4-propoxyphenyl)methyl]piperidine-4-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound E216-1323
1-(6-methyl-3,4-dihydro-2H-1,4-benzoxazine-4-carbonyl)-N-[(4-propoxyphenyl)methyl]piperidine-4-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

E216-1323

Molecular Formula

C26H33N3O4 (C26 H33 N3 O4)

Compound Name

1-(6-methyl-3,4-dihydro-2H-1,4-benzoxazine-4-carbonyl)-N-[(4-propoxyphenyl)methyl]piperidine-4-carboxamide

IUPAC name

1-(6-methyl-34-dihydro-2H-14-benzoxazine-4-carbonyl)-N-[(4-propoxyphenyl)methyl]piperidine-4-carboxamide

SMILES

CCCOc1ccc(CNC(C(CC2)CCN2C(N2c(cc(C)cc3)c3OCC2)=O)=O)cc1

InChI

InChI=1S/C26H33N3O4/c1-3-15-32-22-7-5-20(6-8-22)18-27-25(30)21-10-12-28(13-11-21)26(31)29-14-16-33-24-9-4-19(2)17-23(24)29/h4-9,17,21H,3,10-16,18H2,1-2H3,(H,27,30)

InChI Key

QQZSOIFYHCRRHK-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14847838

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

451.57

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

4.114

Distribution Coefficient, logD

4.114

Water Solubility, LogSw

-4.08

Polar Surface Area

57.139

Acid Dissociation Constant (pKa)

13.57

Base Dissociation Constant (pKb)

1.35

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

46.20

E216-1323 in Drug Discovery

Included in Screening Libraries

MCL1 Targeted Library (12200 compounds)

PI3K-Targeted Library (17255 compounds)

Anti-HIV1 Library (19540 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • Kinases
  • Phosphatases

References: we are preparing a list of scientific research reports with E216-1323 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound E216-1323?
Check Price and Availability of E216-1323, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of E216-1323 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for E216-1323
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for E216-1323
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of E216-1323 available by request